Evasion and subversion of antigen presentation by Mycobacterium tuberculosis: REVIEW ARTICLE

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Mycobacterium tuberculosis is one of the most successful of human pathogens and has acquired the ability to establish latent or progressive infection and persist even in the presence of a fully functioning immune system. The ability of M. tuberculosis to avoid immune-mediated clearance is likely to reflect a highly evolved and coordinated program of immune evasion strategies, including some that interfere with antigen presentation to prevent or alter the quality of T-cell responses. Here, we review an extensive array of published studies supporting the view that antigen presentation pathways are targeted at many points by pathogenic mycobacteria. These studies show the multiple potential mechanisms by which M. tuberculosis may actively inhibit, subvert or otherwise modulate antigen presentation by major histocompatibility complex class I, class II and CD1 molecules. Unraveling the mechanisms by which M. tuberculosis evades or modulates antigen presentation is of critical importance for the development of more effective new vaccines based on live attenuated mycobacterial strains.

Original languageEnglish (US)
Pages (from-to)189-204
Number of pages16
JournalTissue Antigens
Volume74
Issue number3
DOIs
StatePublished - Sep 2009

Fingerprint

Antigen Presentation
Mycobacterium tuberculosis
Immune Evasion
Mycobacterium
Major Histocompatibility Complex
Immune System
Vaccines
T-Lymphocytes
Infection

Keywords

  • Antigen presentation
  • CD1
  • Immune evasion
  • Major histocompatibility complex class I
  • Major histocompatibility complex class II
  • Mycobacterium tuberculosis
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Genetics

Cite this

Evasion and subversion of antigen presentation by Mycobacterium tuberculosis : REVIEW ARTICLE. / Baena, A.; Porcelli, Steven A.

In: Tissue Antigens, Vol. 74, No. 3, 09.2009, p. 189-204.

Research output: Contribution to journalArticle

@article{6050194d890e4b7e89a678f42966adbd,
title = "Evasion and subversion of antigen presentation by Mycobacterium tuberculosis: REVIEW ARTICLE",
abstract = "Mycobacterium tuberculosis is one of the most successful of human pathogens and has acquired the ability to establish latent or progressive infection and persist even in the presence of a fully functioning immune system. The ability of M. tuberculosis to avoid immune-mediated clearance is likely to reflect a highly evolved and coordinated program of immune evasion strategies, including some that interfere with antigen presentation to prevent or alter the quality of T-cell responses. Here, we review an extensive array of published studies supporting the view that antigen presentation pathways are targeted at many points by pathogenic mycobacteria. These studies show the multiple potential mechanisms by which M. tuberculosis may actively inhibit, subvert or otherwise modulate antigen presentation by major histocompatibility complex class I, class II and CD1 molecules. Unraveling the mechanisms by which M. tuberculosis evades or modulates antigen presentation is of critical importance for the development of more effective new vaccines based on live attenuated mycobacterial strains.",
keywords = "Antigen presentation, CD1, Immune evasion, Major histocompatibility complex class I, Major histocompatibility complex class II, Mycobacterium tuberculosis, Vaccine",
author = "A. Baena and Porcelli, {Steven A.}",
year = "2009",
month = "9",
doi = "10.1111/j.1399-0039.2009.01301.x",
language = "English (US)",
volume = "74",
pages = "189--204",
journal = "HLA",
issn = "2059-2302",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Evasion and subversion of antigen presentation by Mycobacterium tuberculosis

T2 - REVIEW ARTICLE

AU - Baena, A.

AU - Porcelli, Steven A.

PY - 2009/9

Y1 - 2009/9

N2 - Mycobacterium tuberculosis is one of the most successful of human pathogens and has acquired the ability to establish latent or progressive infection and persist even in the presence of a fully functioning immune system. The ability of M. tuberculosis to avoid immune-mediated clearance is likely to reflect a highly evolved and coordinated program of immune evasion strategies, including some that interfere with antigen presentation to prevent or alter the quality of T-cell responses. Here, we review an extensive array of published studies supporting the view that antigen presentation pathways are targeted at many points by pathogenic mycobacteria. These studies show the multiple potential mechanisms by which M. tuberculosis may actively inhibit, subvert or otherwise modulate antigen presentation by major histocompatibility complex class I, class II and CD1 molecules. Unraveling the mechanisms by which M. tuberculosis evades or modulates antigen presentation is of critical importance for the development of more effective new vaccines based on live attenuated mycobacterial strains.

AB - Mycobacterium tuberculosis is one of the most successful of human pathogens and has acquired the ability to establish latent or progressive infection and persist even in the presence of a fully functioning immune system. The ability of M. tuberculosis to avoid immune-mediated clearance is likely to reflect a highly evolved and coordinated program of immune evasion strategies, including some that interfere with antigen presentation to prevent or alter the quality of T-cell responses. Here, we review an extensive array of published studies supporting the view that antigen presentation pathways are targeted at many points by pathogenic mycobacteria. These studies show the multiple potential mechanisms by which M. tuberculosis may actively inhibit, subvert or otherwise modulate antigen presentation by major histocompatibility complex class I, class II and CD1 molecules. Unraveling the mechanisms by which M. tuberculosis evades or modulates antigen presentation is of critical importance for the development of more effective new vaccines based on live attenuated mycobacterial strains.

KW - Antigen presentation

KW - CD1

KW - Immune evasion

KW - Major histocompatibility complex class I

KW - Major histocompatibility complex class II

KW - Mycobacterium tuberculosis

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=68249100525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249100525&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0039.2009.01301.x

DO - 10.1111/j.1399-0039.2009.01301.x

M3 - Article

C2 - 19563525

AN - SCOPUS:68249100525

VL - 74

SP - 189

EP - 204

JO - HLA

JF - HLA

SN - 2059-2302

IS - 3

ER -